Canopy Growth Corp (CGC)
3.91
+0.05
(+1.30%)
USD |
NASDAQ |
Nov 22, 16:00
3.91
0.00 (0.00%)
After-Hours: 20:00
Canopy Growth Net Income (Quarterly): -94.01M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -94.01M |
| June 30, 2024 | -92.89M |
| March 31, 2024 | -68.46M |
| December 31, 2023 | -159.25M |
| September 30, 2023 | -231.00M |
| June 30, 2023 | -28.34M |
| March 31, 2023 | -473.08M |
| December 31, 2022 | -191.02M |
| September 30, 2022 | -223.76M |
| June 30, 2022 | -1.633B |
| March 31, 2022 | -459.60M |
| December 31, 2021 | -86.42M |
| September 30, 2021 | -8.780M |
| June 30, 2021 | 319.53M |
| March 31, 2021 | -552.27M |
| December 31, 2020 | -693.94M |
| September 30, 2020 | -24.06M |
| June 30, 2020 | -78.27M |
| March 31, 2020 | -971.78M |
| December 31, 2019 | -69.20M |
| September 30, 2019 | 195.99M |
| June 30, 2019 | -138.89M |
| March 31, 2019 | -290.55M |
| December 31, 2018 | 51.11M |
| September 30, 2018 | -257.88M |
| Date | Value |
|---|---|
| June 30, 2018 | -62.21M |
| March 31, 2018 | -46.30M |
| December 31, 2017 | 1.245M |
| September 30, 2017 | -1.067M |
| June 30, 2017 | -6.730M |
| March 31, 2017 | -9.057M |
| December 31, 2016 | 2.242M |
| September 30, 2016 | 4.163M |
| June 30, 2016 | -3.064M |
| March 31, 2016 | -3.732M |
| December 31, 2015 | -2.483M |
| September 30, 2015 | 3.004M |
| June 30, 2015 | 0.8229M |
| December 31, 2014 | -2.320M |
| September 30, 2014 | -2.183M |
| June 30, 2014 | -1.064M |
| March 31, 2014 | -2.500M |
| January 31, 2014 | -0.0264M |
| October 31, 2013 | -0.007M |
| July 31, 2013 | -0.0366M |
| April 30, 2013 | -0.0048M |
| January 31, 2013 | -0.012M |
| October 31, 2012 | -0.0101M |
| July 31, 2012 | -0.0024M |
| April 30, 2012 | -0.0076M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-1.633B
Minimum
Jun 2022
319.53M
Maximum
Jun 2021
-290.97M
Average
-126.63M
Median
Net Income (Quarterly) Benchmarks
| Tilray Brands Inc | -39.16M |
| Aurinia Pharmaceuticals Inc | 14.35M |
| Edesa Biotech Inc | -1.668M |
| Lexaria Bioscience Corp | -1.782M |
| Xenon Pharmaceuticals Inc | -62.79M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 46.16M |
| Total Expenses (Quarterly) | 61.68M |
| EPS Diluted (Quarterly) | -1.084 |
| Enterprise Value | 645.48M |
| Gross Profit Margin (Quarterly) | 34.67% |
| Profit Margin (Quarterly) | -203.7% |
| Earnings Yield | -120.3% |
| Normalized Earnings Yield | -68.65 |